Canada Dnases Market Size & Outlook, 2023-2030

The dnases market in Canada is expected to reach a projected revenue of US$ 15.3 million by 2030. A compound annual growth rate of 10.7% is expected of Canada dnases market from 2024 to 2030.
Revenue, 2023 (US$M)
$7.5
Forecast, 2030 (US$M)
$15.3
CAGR, 2024 - 2030
10.7%
Report Coverage
Canada

Canada dnases market highlights

  • The Canada dnases market generated a revenue of USD 7.5 million in 2023 and is expected to reach USD 15.3 million by 2030.
  • The Canada market is expected to grow at a CAGR of 10.7% from 2024 to 2030.
  • In terms of segment, biopharmaceutical processing was the largest revenue generating application in 2023.
  • Other Applications is the most lucrative application segment registering the fastest growth during the forecast period.

Dnases market data book summary

Market revenue in 2023USD 7.5 million
Market revenue in 2030USD 15.3 million
Growth rate10.7% (CAGR from 2023 to 2030)
Largest segmentBiopharmaceutical processing
Fastest growing segmentOther Applications
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBiopharmaceutical Processing, Other Applications
Key market players worldwideThermo Fisher Scientific Inc, Merck KGaA, Agilent Technologies Inc, Promega, New England Biolabs, RayBiotech, Qiagen NV, Takara Bio Inc, Abnova, Worthington Enterprises Inc, MyBiosource, Sino Biological, Biovision, Calzyme, ArcticZymes Technologies, MBL International Corporation, BPS Bioscience Inc., Bio-Techne Corp, ABclonal

Other key industry trends

  • In terms of revenue, Canada accounted for 3.1% of the global dnases market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. dnases market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 15.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

DNAses Market Companies

Name Profile # Employees HQ Website

Canada dnases market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dnases market will help companies and investors design strategic landscapes.


Biopharmaceutical processing was the largest segment with a revenue share of 76% in 2023. Horizon Databook has segmented the Canada dnases market based on biopharmaceutical processing, other applications covering the revenue growth of each sub-segment from 2018 to 2030.


  • Canada DNAses Application Outlook (Revenue, USD Million, 2018-2030)
    • Biopharmaceutical Processing
    • Oligonucleotide synthesis
    • mRNA Production
    • Other Applications

Reasons to subscribe to Canada dnases market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Canada dnases market databook

  • Our clientele includes a mix of dnases market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Canada dnases market, including forecasts for subscribers. This country databook contains high-level insights into Canada dnases market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Canada dnases market size, by application, 2018-2030 (US$M)

Canada DNAses Market Share, 2023 & 2030 (US$M)

Canada dnases market size, by application, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more